HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 73 filers reported holding HOOKIPA PHARMA INC in Q2 2021. The put-call ratio across all filers is 8.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $747,000 | -60.6% | 320,444 | -0.5% | 0.19% | -62.6% |
| Q3 2021 | $1,897,000 | -35.7% | 322,124 | 0.0% | 0.50% | -18.5% |
| Q2 2021 | $2,951,000 | -36.1% | 322,124 | -6.2% | 0.62% | -43.7% |
| Q1 2021 | $4,619,000 | +66.6% | 343,455 | +37.4% | 1.10% | +32.8% |
| Q4 2020 | $2,773,000 | +1226.8% | 250,000 | +1033.2% | 0.82% | +1113.2% |
| Q3 2020 | $209,000 | -77.6% | 22,061 | -72.5% | 0.07% | -74.7% |
| Q2 2020 | $931,000 | – | 80,118 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
| Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
| Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
| HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
| DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
| Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
| HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
| Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |